NCT02119845View on ClinicalTrials.gov

A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol FLEX-1-001

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Chronic Kidney Disease (CKD)
Interventions
DEVICE

Endovascular AVF (EndoAVF)

The FLEX System will be used to endovascularly create a fistula in CKD patients who require hemodialysis vascular access.

Trial Locations (1)

1001-1925

Italian Hospital, Asunción

All Listed Sponsors
lead

TVA Medical Inc.

INDUSTRY

NCT02119845 - A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol FLEX-1-001 | Biotech Hunter | Biotech Hunter